Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock by Busik, Julia V. et al.
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 206 No. 13  2897-2906
www.jem.org/cgi/doi/10.1084/jem.20090889
2897
Brief Definitive Report
Endothelial dysfunction is central to the devel-
opment of diabetic macro- and microvascular 
complications, and it is these complications that 
contribute to the major morbidity and mortality 
for diabetic patients. Bone marrow–derived pro-
genitor cells play a critical role in endothelial re-
pair (Asahara et al., 1997; Grant et al., 2002). 
Endothelial progenitor cells (EPCs) arising from 
the bone marrow circulate in the bloodstream 
and home to areas of injury to orchestrate vascu-
lar repair (Grant et al., 2002). Recently, it was 
determined that the release of all bone marrow–
derived cells occurs in a distinct circadian pattern 
(Méndez-Ferrer  et  al.,  2008).  The  suprachias-
matic nucleus (SCN) in the central nervous sys-
tem  initiates  this  and  other  circadian  rhythms   
as well as synchronizing peripheral clocks in or-
gans and tissues. Circadian rhythms occur via   
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The present epidemic of diabetes is resulting in a worldwide increase in cardiovascular and 
microvascular complications including retinopathy. Current thinking has focused on local 
influences in the retina as being responsible for development of this diabetic complication. 
However, the contribution of circulating cells in maintenance, repair, and dysfunction of 
the vasculature is now becoming appreciated. Diabetic individuals have fewer endothelial 
progenitor cells (EPCs) in their circulation and these cells have diminished migratory poten-
tial, which contributes to their decreased reparative capacity. Using a rat model of type 2 
diabetes, we show that the decrease in EPC release from diabetic bone marrow is caused by 
bone marrow neuropathy and that these changes precede the development of diabetic 
retinopathy. In rats that had diabetes for 4 mo, we observed a dramatic reduction in the 
number of nerve terminal endings in the bone marrow. Denervation was accompanied by 
increased numbers of EPCs within the bone marrow but decreased numbers in circulation. 
Furthermore, denervation was accompanied by a loss of circadian release of EPCs and a 
marked reduction in clock gene expression in the retina and in EPCs themselves. This reduc-
tion in the circadian peak of EPC release led to diminished reparative capacity, resulting in 
the development of the hallmark feature of diabetic retinopathy, acellular retinal capillar-
ies. Thus, for the first time, diabetic retinopathy is related to neuropathy of the bone 
marrow. This novel finding shows that bone marrow denervation represents a new thera-
peutic target for treatment of diabetic vascular complications.
© 2009 Busik et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Figure 1.  Dramatic decrease in humerus bone marrow innervation in diabetic rats is associated with an increase in retinal acellular capil-
laries. (A and B) NF200-positive nerve processes (arrowheads) are visible in bone marrow of control rats (A and A) but significantly decreased in diabetic 
rats (B and B). (C and D) TH-positive nerve processes running along blood vessels (arrows) were present in the bone marrow of controls (C and C) but 
very rare in diabetic animals (D and D). (E and G) No staining was found in negative controls treated only with secondary antibody. Bars: (A–D) 20 µM; 
(A–D, E, and G) 5 µM. (F and H) Quantification of the NF200 and TH data are shown in F and H, respectively. Diaphysis of the humerus bone from control 
(n = 4) and diabetic (n = 3) animals were assessed. At least 10 fields per humerus were analyzed on duplicate slides from each bone by three independent 
individuals. *, P < 0.05. The experiment was repeated on two independent sets of animals. (I and J) Retinal vasculature from control (I) and diabetic  
(J) animals was prepared using trypsin digestion and stained with hematoxylin and periodic acid–Schiff. Dramatically increased number of acellular capil-
laries (black arrows) was observed in retinal vasculature isolated from diabetic animals (I) compared with control (J). (K) Quantification of I and J. Bars,  
10 µM. The data represent mean ± SD of three independent sets of animals, with nine control and nine diabetic animals total. At least eight fields per 
retina were counted in duplicates by two independent investigators. ***, P < 0.001.JEM VOL. 206, December 21, 2009  2899
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Figure 2.  Denervation of the bone marrow precedes acellular capillaries formation in diabetic rats after 2 mo of diabetes. (A and B) TH-positive 
nerve processes running along blood vessel (arrow) were present in diabetic bone marrow at 2 mo of diabetes (A and A) but were significantly decreased 
compared with controls (B). At least 10 fields were analyzed on duplicate slides from each bone by three independent individuals. Bars: (A) 20 µm; (A) 5 µm. 
*, P < 0.05. The experiment was repeated on two independent sets of animals. Data are presented as the mean ± SD of four control and three diabetic 
(A and B) rats. (C) On the contrary, the number of acellular capillaries was not changed. Data in C are presented as the mean of two independent sets of 
animals, with six control and six diabetic rats total. At least eight fields per retina were counted in duplicates by two independent investigators. *, P < 0.05.
autoregulatory transcriptional-translational feedback loops con-
sisting of a defined set of clock genes. Pathological clock gene 
expression leads to diverse pathophysiological disorders includ-
ing metabolic syndrome, obesity, premature aging, and abnor-
mal sleep cycle (Weber, 2009). The physiological relevance of a 
disturbed circadian rhythm in diabetes is indicated by the obser-
vation that myocardial dysfunction, acute coronary syndrome, 
sudden cardiac death, and ischemic stroke occur with peak in-
cidence in nondiabetics in the early morning, yet in diabetic 
patients the peak is at night (Weston and Gill, 1999; Ruiter   
et al., 2006; Ikeda et al., 2007; Peschke, 2008; Thomas et al., 
2008). Interestingly, db/db mice, a model of type 2 diabetes, 
have disrupted circadian variation of blood pressure, heart rate, 
and locomotor activity, which are each associated with damp-
ened oscillations of peripheral clock genes (Su et al., 2008).
Mobilization of EPC from the bone marrow occurs after 
activation of peripheral noradrenergic neurons and release of 
norepinephrine (NE), which suppresses osteoblast activity 
(Serre et al., 1999; Méndez-Ferrer et al., 2008). This results in 
a local decrease in SDF-1 (stromal-derived factor 1) and sub-
sequent EPC mobilization from the bone marrow (Katayama 
et al., 2006). Advanced diabetes is associated with neuropathy 
(Said, 2007). We reasoned that diabetes-associated peripheral 
and/or autonomic neuropathy would reduce bone marrow 
innervation and thus reduce hematopoietic stem cell (HSC)/
EPC release from the bone marrow. Decrease in circulating 
EPCs would reduce repair of injured retinal vessels in diabetics 
and lead to development of acellular capillaries, the hallmark 
feature of irreversible diabetic retinopathy.
RESULTS AND DISCUSSION
BBZDR/Wor rats with 4 mo of diabetes were used and com-
pared with their age-matched nondiabetic BBDR littermates. 
The BBZDR/Wor rat was specifically developed as a model 
of type 2 diabetes that develops diabetic complications. Male 
obese BBZDR/Wor rats spontaneously develop diabetes that 
mimics human type 2 diabetes, and this typically occurs at 74 d 
of age. They demonstrate hyperglycemia and dyslipidemia, 
which are typical of type 2 diabetes, with increased levels of 
cholesterol, triglycerides, and nonesterified fatty acids (Tirabassi 
et al., 2004). The BBZDR/Wor rat develops retinopathy, 
neuropathy, nephropathy, and macrovascular complications 
typical of human type 2 diabetes and is emerging as the most 
applicable model of type 2 diabetic complications (Tirabassi 
et  al.,  2004).  BBZDR/Wor  animals  demonstrate  increased 
vascular endothelial growth factor (VEGF) production and in-
creased VEGF receptor expression (Ellis et al., 2000), as well 
as increased NADPH oxidase activity (Ellis et al., 1998) and 
hydrogen peroxide production (Ellis et al., 2000) in the retinal 
vasculature as early as 2 wk after diabetes onset. BBZDR/Wor 
rats also progress to early preproliferative diabetic retinopathy 
with the development of acellular capillaries, pericyte ghosts, 
and capillary basement membrane thickening after 4 mo of 
diabetes (Tirabassi et al., 2004).2900 Retinopathy is linked to bone marrow neuropathy | Busik et al.
pathology because at 2 mo of diabetes, the rats did not have 
any retinal histopathological changes (Fig. 2 C) but already 
showed early signs of denervation (Fig. 2, A and B).
In these studies, we characterized the progenitor popula-
tion based on surface expression of thy-1 and CD133 (Peichev 
et al., 2000), endothelial nitric oxide synthase expression 
(Loomans et al., 2006), and the ability of these cells to incor-
porate into capillary tubes in vitro (Schatteman et al., 2007; 
Fig. 3). To determine whether denervation of bone marrow 
affected circadian EPC release in diabetes, peripheral blood 
EPCs were enumerated by flow cytometry analysis every 2 h 
in diabetic rats and compared with age-matched controls. 
Control rats showed a dramatic peak of circulating EPCs be-
tween ZT (Zeitgeber time) 1 and ZT-5 (Fig. 4 A). In con-
trast, diabetic animals exhibited a marked reduction in the 
amplitude and a broader peak in the number of circulating 
EPCs between ZT-21 and ZT-7. Moreover, the controls 
To explore the role of the sympathetic nervous system in 
the release of EPCs in diabetes, we first undertook an analysis 
of bone marrow histology and determined 24-h circulating 
NE levels. Histological examination of the bone marrow in 
rats with 4 mo of diabetes revealed a marked reduction in the 
number of nerve endings as determined by neurofilament 200 
(NF200) staining and increased bone marrow lipid deposition 
compared with age-matched controls (Fig. 1, A–F). Tyrosine 
hydroxylase (TH) staining showed positive nerve processes 
running along blood vessels in the bone marrow of controls 
(Fig. 1, C and C) but was very rarely found in diabetic ani-
mals (Fig. 1, D and D), demonstrating a defect in sympathetic 
innervation. As shown in Fig. 1, 4 mo of diabetes resulted in 
the appearance of increased numbers of acellular capillaries 
within the retina (Fig. 1, J and K) compared with age-matched 
controls (Fig. 1, I and K). We observed that denervation of 
the bone marrow preceded the development of this retinal 
Figure 3.  Rat thy-1+ cell characterization. Thy-1+ cells isolated from rat bone marrow were analyzed by FACS for progenitor marker expression.  
(A–C) Isolated cells express CD133 (A), Thy-1 (B), and VEGFR-2 (C). The red line represents the samples incubated with respective antibody. The black line 
in the representative histogram plot corresponds to the samples incubated with the appropriate isotope control antibodies. (D) Thy-1+ progenitors express 
endothelial nitric oxide synthase (green) as detected by immunofluorescence with nuclei stained with DAPI (blue). Bar, 10 µM. (E and F) Cells in culture 
form colonies (E) and incorporate Dil-acLDL (red; F). Thy-1+ cells incorporate into capillary tubes with human retinal endothelial cells. (G) Fluorescently 
labeled Thy-1 cells (red) incorporating into HRECs. (H) Phase contrast image of same region as in G. (I) Merged phase contrast and fluorescence images of 
Thy-1+ cells (red) participating in tube formation. Bar, 100 µM. Flow cytometry data are represented as percentage of cells expressing respective marker 
for rats (n = 3). Images are representative of n = 4 of individual experiments.JEM VOL. 206, December 21, 2009  2901
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Figure 4.  Diabetes decreases circadian release of EPCs. (A) Control (n = 4) and diabetic (n = 3) rats were maintained on a 12/12 h light/dark cycle 
(lights on at ZT-0, lights off at ZT-12). 100 µl of blood was taken every 2 h and analyzed for the number of EPCs by flow cytometry. EPCs were determined 
as number of thy-1+CD3CD4CD8 cells per µl of blood. There is a clear peak in the EPC number at ZT-3 in control animals (red line). However, the re-
sponse is blunted in Type 2 (blue line) diabetic animals. The number of EPCs in blood was consistently lower in type 2 diabetic animals compared with 
control animals. The data represent the mean ± SD. The experiment was performed on two independent sets of animals, with 12 repetitions per animal. 
Statistical analysis was performed using two-way ANOVA for diabetes and time effect (***, P < 0.0001) and Bonferroni post-test to compare replicates by 
row (*, P < 0.05; ***, P < 0.001). (B) Circadian variation in the number of bone marrow–derived cells in the retinal circulation of mice. Retinal flat mounts 
from gfp+ chimeric control mice show increased numbers of bone marrow–derived circulating cells (green) in the retinal capillaries at ZT-5 (B and B)  
as compared with ZT-13 (C and C). 10 fields per retina were evaluated and both retinas per mouse were analyzed. Magnification is 4× in B and C and  
20× in B and C. Bars: (B and C) 100 µm; (B and C) 10 µm. (D) Quantification of gfp+ cells shows an increase in green fluorescence in retinal capillaries 
at ZT-5 as compared with ZT-13 (n = 4; ***, P < 0.001). The data represents mean ± SE. The experiment was performed on three independent sets of ani-
mals, with the total number of mice per time point equal to nine.2902 Retinopathy is linked to bone marrow neuropathy | Busik et al.
stably engrafted for 4 mo. Retinal flat mounts were prepared 
from animals euthanized at either ZT-5 (peak of rest phase 
in mice) or ZT-13 (trough of EPC release in circulation). 
In agreement with thy-1 enumeration data in healthy rats 
(Fig. 4 A), many more gfp+ cells were present in the retinal 
circulation at the peak release for mice, ZT-5, as compared 
with ZT-13 (Fig. 4, B–D).
We  thus  postulated  that  in  diabetes,  the  EPCs  were 
trapped within the diabetic bone marrow as a result of a lack 
of sympathetic innervation and reduced NE release. To test 
this, we examined the bone marrow in the same rats that un-
derwent 24-h blood sampling for EPC enumeration. These 
diabetic rats with decreased peripheral blood EPCs showed a 
marked elevation in the number of bone marrow EPCs 
demonstrated a dramatic drop to baseline EPC numbers im-
mediately after the ZT-3 peak. In contrast, diabetic rats lost 
this abrupt drop. This finding was confirmed in the type 1 
diabetic animal model (Fig. S1 A).
We  interpreted  the  persistent  elevation  of  EPCs  until 
ZT-7  in  diabetics  as  reduced  release  and  also  diminished 
clearance of these cells from the blood. This reduced clear-
ance was likely the result of a diminished ability of EPCs to 
migrate into tissues from the circulation and is in keeping 
with the profound migratory defect of these cells observed in 
diabetes (Segal et al., 2006; Fig. S3).
To further explore this possibility, we generated chimeric 
mice that underwent transplantation with bone marrow 
HSCs from gfp homozygous transgenic mice and then were 
Figure 5.  Characterization of thy-1+ EPC number and function in type 2 diabetic rats. (A) Diabetic rats (n = 3; black) with decreased peripheral 
blood EPCs showed a marked increase in the number of bone marrow EPCs compared with controls (n = 6; white). (B) Diabetic bone marrow (black) 
showed a reduction in CFU compared with healthy controls (white). (C and D) Typical colony formation observed from explanted control (C) and diabetic 
EPCs (D). Bars, 100 µM. (E) Both blood and bone marrow EPCs of diabetic origin (black) demonstrate reduced migration to VEGF compared with control 
(white). (F) Diabetic bone marrow EPCs (black) show reduced proliferation compared with control cells (white). The data represent the mean ± SE of mini-
mum of four separate experiments. *, P < 0.05.JEM VOL. 206, December 21, 2009  2903
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Figure 6.  Clock gene expression analysis. Rats used in the circadian rhythm study were sacrificed during the peak time of EPC release, ZT1–5, 24 h 
after blood collection. (A–D) RNA extracted from total retina (A), peripheral blood thy-1+ (B), bone marrow thy-1+ populations (C) and SCN (D) were ana-
lyzed for the clock genes Clock, Bmal1, Per1, Per2, CRY1, CRY2, ERB, and RORA. Clock genes demonstrate reduced expression in the diabetic retinas and 
thy-1+ cells. In the bone marrow fraction, Bmal1 and Per2 were significantly reduced in diabetic animals. Although changes in SCN were not significant, 
means for all clock genes were lower in diabetes. The mRNA expression levels were normalized to cyclophilin and expressed as fold change over control 
animals. (E) Western blotting from the retina demonstrated reduction of BMAL in diabetes. The quantitative PCR data are presented as the mean ± SE and 
the Western blotting represents a mean ± SD of four control and three diabetic animals. The experiment was performed on two independent sets of ani-
mals with triplicate measurements for quantitative PCR and duplicate Western blots. *, P < 0.05 compared with control.
compared with controls (Fig. 5 A). In addition, diabetic bone 
marrow EPCs showed a reduction in colony formation abil-
ity (Fig. 5, B–D) and proliferation (Fig. 5 F). Both blood and 
bone marrow EPCs had a reduced migration to VEGF 
(Fig. 5 E) compared with age-matched controls.
We reasoned that circulating NE levels in these diabetic 
animals with peripheral neuropathy and retinopathy may be 
altered and then measured NE levels in the blood of these rats. 
Control rats had two distinct peaks of plasma NE levels, one at 
ZT-1 and one at ZT-13 (Fig. S1 B). Interestingly, in diabetic 
animals, the first NE peak at ZT-1 was considerably higher and 
broader than in controls, showing a compensatory adrenal re-
sponse, whereas the second peak at ZT-13 was absent, sup-
porting the concept of sympathetic dysfunction in these rats.
These experiments demonstrate that type 2 diabetes is 
associated with a reduction in circadian release of EPCs from 
the bone marrow. Because circadian rhythm is under tight 
control of not only the central clock, the SCN, but also pe-
ripheral clocks, we next examined whether clock gene ex-
pression in the SCN, retina, bone marrow, and peripheral 
blood EPCs was altered in diabetes. At peak release of EPCs, 
animals were sacrificed and their SCN brain regions, retinas, 
bone marrow, and peripheral blood harvested for messenger 
RNA (mRNA) extraction. Clock genes (Clock, Bmal1, Per-1, 
Per-2, CRY-1, CRY-2, ERB, and RORA) were quantified 
by real-time PCR in these tissues and cells. Rats with diabe-
tes demonstrated a significant decrease (P < 0.05) in expres-
sion of these clock genes in the retina and in thy-1+ cells 2904 Retinopathy is linked to bone marrow neuropathy | Busik et al.
MATERIALS AND METHODS
Femoral arterial catheterization. The protocols for the rat studies were 
approved by the Institutional Animal Care and Use Committee at Michigan 
State University, The University of Florida, and Biomedical Research Mod-
els, Inc. Multiple blood draws were performed by direct catheter placement 
into the femoral artery and vein. Animals were anesthetized with isoflurane 
(2%). The surgical approach for the femoral arterial catheters was through 
the ventral aspect of the leg. The catheters were tunneled subcutaneously to 
the nape of the neck and secured with sutures for later access while the ani-
mals were conscious. Blood draws were initiated after complete recovery of 
the animal, as determined by healing of the incision sites, usually 3–4 d after 
surgery. Blood draws (100 µl each) were performed every 2 h for 24 h using 
an Automatic Blood Sampler (DiLab).
Isolation of thy-1+ cells from bone marrow. Rats were euthanized by 
exsanguination after anesthesia. Rat hind limb bones were dislocated and the 
skin removed. Bones were flushed with ice cold PBS and the cells pelleted. 
The cells were then treated with ammonium chloride (STEMCELL Tech-
nologies Inc.) to remove any contaminating red blood cells and resuspended 
in PBS (Mediatech, Inc.) containing 2% FBS and 1 mM EDTA. A custom rat 
negative selection kit (STEMCELL Technologies Inc.) was used to deplete 
CD4, CD5, CD8a, and OX-43 cells of the rat. The cells were then further 
enriched for CD90 (thy-1)-positive cells using a positive selection kit (STEM-
CELL Technologies Inc.) tagged with a CD90/thy-1 antibody (Abcam).
Flow cytometry analysis. A flow cytometer (LSR II; BD) equipped with 
FACSDiva software (BD) was used for thy-1+CD3CD4CD8 cell enu-
meration.  PerCP-Cy5.5–  (eBioscience),  FITC-,  RPE-,  and  Alexa  Fluor 
647–conjugated mouse anti–rat antibodies (AbD Serotec) were used to stain 
thy-1, CD3, CD4, and CD8 surface markers, respectively, in concentrations 
according to the manufacturer’s instructions. PerCP-Cy5.5, FITC, and RPE 
were excited at 488 nm and their respective fluorescent emission was de-
tected at 695, 530, and 576 nm. Alexa Fluor 647 was excited at 633 nm and 
its emission detected at 660 nm. Isotype-negative samples for all antibodies 
were used to determine the background fluorescence for each fluorochrome. 
Single-stained samples were used to set color compensation between fluoro-
chromes. A gate was drawn around the white blood cell population in a for-
ward versus side scatter histogram to exclude red blood cells debris.
NE ELISA. A competitive ELISA kit (ALPCO Diagnostics) was used to de-
termine NE levels in 10 µl of rat plasma according to the manufacturer’s in-
structions. In summary, NE was first extracted with a cis-diol–specific affinity 
gel and then acylated and converted enzymatically. After transfer on antiserum-
covered microtiter plates, derivatized samples competed with solid phase–
bound analytes for a fixed number of binding sites. After free analytes were 
removed by washing, the antibody bound to the solid phase was detected by 
peroxidase conjugation and read at 450 nm. Absorbance reading of the stan-
dards (linear) was plotted against known standard concentrations (logarithmic) 
and a standard curve was drawn to quantify unknown samples.
Immunohistochemistry. Decalcified rat humerus bones were embedded in 
paraffin, sectioned on a rotary microtome at 4 µm, and then dried and de-
paraffinized. Enzymatic epitope retrieval was performed. After pretreatments, 
standard Avidin–Biotin complex staining steps were performed at room tem-
perature on an Autostainer (Dako). After blocking nonspecific protein with 
nonimmune goat serum (Vector Laboratories), sections were incubated with 
an  Avidin  (Vector  Laboratories)/Biotin  (Sigma-Aldrich)  blocking  system. 
Polyclonal rabbit anti-NF200 (Sigma-Aldrich) at 1:100 or polyclonal rabbit 
anti-TH (Millipore) at 1:100 in normal antibody diluent (ScyTek Laborato-
ries) was used for staining. Biotinylated secondary goat anti–rabbit IgG (Vector 
Laboratories) in normal antibody diluent diluted 1:400, followed by R.T.U. 
Elite Peroxidase reagent (Vector Laboratories), was applied for visualization. 
The slides were developed using Nova red (Vector Laboratories), counter-
stained using Gill (Lerner) 2 Hematoxylin (Thermo Fisher Scientific), dehy-
drated, cleared, and mounted using Permount (Thermo Fisher Scientific).
isolated from both blood and bone marrow (Fig. 6, A–C). 
Protein studies revealed reduction in Bmal expression in dia-
betic rats as compared with controls (Fig. 6 E). This dramatic 
reduction in both the positive and negative arms of circadian 
gene regulators would lead to dampened oscillations and 
lower and broader peaks, which is the pattern we observed in 
the circulating EPCs in diabetic rats compared with age-
matched controls. Healthy rats, in contrast, demonstrated a 
higher narrower peak than the diabetic rats. Although ex-
pression of clock genes was reduced in the SCN regions of 
diabetic rats, the difference from controls was not significant 
(Fig. 6 D). This lack of change suggests that diabetes is associ-
ated with dysfunction of the peripheral rather than the central 
clock. The mRNA and protein expression of clock genes in 
control and diabetic human retina (Fig. S2) is in agreement 
with the alterations of clock gene expression found in the 
diabetic rat model.
The potential to form new blood vessels and repair dam-
aged vessels depends on the EPCs’ ability to both leave the 
bone marrow and to migrate toward the site of angiogenesis. 
In this study, we observed that type 2 diabetic rats demon-
strate the hallmark feature of diabetic retinopathy, acellular 
capillaries within the retina, at the precise time when there is 
denervation of the bone marrow and a reduction in peripheral 
clock gene expression. The resultant acellular capillaries seen 
at 4 mo of diabetes appear to be caused, in part, by the loss of 
proper EPC reparative function and by failure of circadian 
EPC release secondary to diabetes-associated denervation of 
the bone marrow. In the presence of innervation, as observed 
in control rats, there was normal retinal histology and a robust 
circadian release of EPC from the bone marrow. We report 
that by 4 mo of diabetes in our model of type 2 diabetes, there 
is inherent sympathetic denervation that can alter circadian 
release of EPC from the bone marrow. Our data supports that 
the loss of circadian EPC release results in inadequate levels of 
cells in the circulation at the optimal time of repair (rest phase) 
and that this defect, in addition to defects of EPC function 
(reduced proliferation and migration), contributes to the de-
velopment of diabetic retinopathy.
Circadian dysfunction itself can have profound effects on 
the diabetic state. Prior work has shown that mice with a 
specific clock gene mutation demonstrate impaired endothe-
lial function, including decreased tube formation and faster 
senescence and impaired EPC-mediated repair (Wang et al., 
2008). Other clock genes have been shown to directly regu-
late glucose homeostasis, and their inactivation suppresses di-
urnal variation in glucose and triglycerides along with reduced 
gluconeogenesis (Kohsaka et al., 2007). Our novel findings 
would indicate that restoration of sympathetic innervation to 
the diabetic bone marrow should result in physiological EPC 
egress from the bone marrow and improved retinal vascular 
repair (Thomas et al., 2008). Moreover, strategies to normal-
ize peripheral clock gene expression may be a novel way to 
both treat and prevent the development of diabetic macro- 
and microvascular complications by circumventing sympa-
thetic nervous system dysfunction.JEM VOL. 206, December 21, 2009  2905
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Retinal vasculature preparation. The sensory retina was isolated by gently 
separating it from pigment epithelium and choroid using a #00 paint brush un-
der a dissecting microscope, prepared using trypsin digestion, and stained with 
hematoxylin and periodic acid–Schiff (Mizutani et al., 1996). Acellular capillar-
ies were quantified in a masked manner by three independent examiners.
gfp bone marrow chimeric mice. 10–12-wk-old female C57BL6/J mice 
were lethally irradiated and then their bone marrow was reconstituted with 
lineage-negative Sca1+ c-kit+ HSCs from donor bone marrow of transgenic 
mice homozygous for gfp, according to methods published previously (Grant 
et al., 2002). At selected times (ZT-5 And ZT-13) mice were euthanized and 
blood was collected for enumeration of thy-1+gfp+ circulating cells. The eyes 
were enucleated and preserved, retinas dissected, and mounted flat and image 
captures made using a fluorescent microscope (Eclipse TE200; Nikon) equipped 
with a digital camera (SPOT0.60XHRD06-NIK; Diagnostic Instruments, Inc.).
Real-time quantitative RT-PCR. Rat retinas and bone marrow or blood 
EPCs were homogenized in Trizol reagent (Invitrogen), and RNA was iso-
lated according to the manufacturer’s instructions. First-strand complemen-
tary DNA was synthesized from isolated RNA using SuperScript II reverse 
transcription (Invitrogen). Prepared complementary DNA was mixed with 
2× SYBR Green PCR Master Mix (Applied Biosystems) and various sets of 
gene-specific (Table S1) forward and reverse primers and subjected to real-
time PCR quantification using the ABI PRISM 7700 Sequence Detection 
System (Applied Biosystems). All reactions were performed in triplicate. The 
relative amounts of mRNAs were calculated using the comparative thresh-
old cycle method. Cyclophilin was used as a control, and all results were 
normalized to the abundance of cyclophilin.
Thymidine proliferation assay. 30,000 EPCs were plated per well using 
a 24-well plate and then treated with cytokine mix (Stem Cell Technolo-
gies) for 12 h. Thymidine was diluted 1:10 in PBS and added to the wells di-
rectly. The cells were then placed in the CO2 incubator for 2 h. Then cells 
were removed, spun at 5,000 rpm for 5 min, and washed with ice cold 10% 
TCA (×2). 0.2 M NaOH was added to the cells and the plates were shaken 
gently for 10 min at room temperature. 100 µl of cell homogenate was then 
added to 4 ml Cytoscint (Thermo Fisher Scientific). CPM was counted us-
ing thymidine settings.
Online supplemental material. Fig. S1 depicts decreased number of cir-
culating EPCs in a type 1 diabetes model, increased plasma levels of NE in a 
type 2 diabetes model, and decreased number of circulating CD3-positive 
cells in a type 2 model as compared with controls. In Fig. S2, we show that 
clock genes demonstrate altered mRNA and protein levels in human dia-
betic retina. Fig. S3 illustrates that normal, but not diabetic, human EPC 
may participate in ocular vascular reendothelialization in diabetic mice. 
Table S1 shows real-time RT-PCR primers. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20090889/DC1.
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